作者:
Rinne, Juha O. [1]
;
Brooks, David J. [2]
;
Rossor, Martin N. [3]
;
Fox, Nick C. [4]
;
Bullock, Roger [5]
;
Klunk, William E. [6]
;
Mathis, Chester A. [7]
;
Blennow, Kaj [8]
;
Barakos, Jerome [9]
;
Okello, Aren A. [10]
;
de Llano, Sofia Rodriguez Martinez ;
Liu, Enchi ;
Koller, Martin ;
Gregg, Keith M. ;
Schenk, Dale ;
Black, Ronald ;
Grundman, Michael
作者单位:
Pfizer, Collegeville, PA USA
[1]
Calif Pacific Med Ctr, San Francisco, CA USA
[2]
Janssen Alzheimer Immunotherapy, San Francisco, CA USA
[3]
Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[4]
Elan Pharmaceut, San Francisco, CA USA
[5]
UCL, Inst Neurol, London, England
[6]
Kingshill Res Ctr, Swindon, Wilts, England
[7]
Univ Goteborg, Sahlgrenska Univ Hosp, Molndal, Sweden
[8]
Univ Turku, Turku PET Ctr, Turku 20521, Finland
[9]
Univ London Imperial Coll Sci Technol & Med, Div Neurosci, Fac Med, London, England
[10]
发布时间
2016-01-18